Evaluation of human papillomavirus (HPV) diversity in various grades of cervical lesions is helpful for understanding the characteristics of HPV infection in the pathogenesis of cervical neoplasia. A total of 227 women with normal cervices (n = 72), low-and high-grade cervical squamous intraepithelial lesions (SILs) (n = 55 and 53, respectively) and cervical carcinomas (n = 47) were screened for human papillomavirus (HPV) types 6, 11, 16 and 18 infection by the polymerase chain reaction. The prevalence of multiple HPV infections in patients with normal cervices, low-grade SILs, high-grade SILs and cervical carcinomas was 22.2%, 6l.8%, 41.5% and 21.3%, respectively, while the prevalence of a single-type infection was 36.1%, 2l.8%, 30.2% and 61.7%, respectively. HPV 16/11 and 16/18 were the most common combinations observed in multiple infections. Multiple HPV infections were seen most frequently in patients with low-grade SILs, and the prevalence decreased with increasing severity of cervical neoplasia. In contrast, infection with a single HPV type was most commonly observed in patients with cervical carcinoma, and the prevalence decreased with decreasing severity of cervical neoplasia. HPV 16 was the predominant single-type infection in patients with cervical carcinoma and this prevalence decreased steadily with decreasing severity of cervical neoplasia. Conversely, HPV 11 was the predominant single-type infection in patients with normal cervices. This prevalence decreased with increasing severity of cervical neoplasia. Patients with low-grade SILs had a higher prevalence of HPVs, regardless of single or multiple infection status, and larger copy numbers of virus genome were seen more frequently in patients with more severe lesions.
Introduction
Human papillomaviruses (HPVs) are known to be associated with cervical neoplasms. More than 60 HPV genotypes have been characterised and at least 22 genotypes have been indentified in genital tract infection [I, 21. Among them, HPV types 6 and 11 are commonly associated with benign lesions such as condylomata acuminata, whereas types 16 and 18 are more frequently associated with cervical malignancy [3-51. In-vitro studies of HPV types 6 and 11 have indicated that they do not share the oncogenic potential of HPV 16 and 18 but, occasionally, HPV 6 and 11 may be found in some malignant lesions [6] .
Cervical neoplasia, including squamous intra-epithelial lesions (SILs) and cervical cancer, represent a group of heterogeneous diseases from a virological viewpoint [7, 8] . There is considerable variation in the prevalence of HPV infection within each lesion group. Women with cervical cancer have HPV types 16 and 18 infection more frequently than women with normal cervices [9] . The prevalence of HPV types 16 and 18 increases with increasing severity of cervical neoplasia [lo] . Conversely, HPV types 6 and 11 are seldom found in cervical cancer but appear to be more frequent in SILs than in normal cervices [I 11 . The management of patients with HPV infection may be influenced by the infecting HPV type as well as by routine histological examination of the lesions [ 121. Evaluation of HPV diversity in various grades of cervical lesions is helpful for understanding the characteristics of HPV infection in the pathogenesis of cervical neoplasia.
sequences from tissues that give negative results by Southern blot hybridisation [ 14-171. Hence, more cases with small copy numbers of HPV DNA, such as those with latent or subclinical infection, become detectable by PCR. The epidemiological data of HPV infection obtained by applying the PCR will be different from that obtained by other conventional hybridisation methods. As the use of PCR increases, reports of multiple infections will be more common. The interactions between different types of HPV during the progression of cervical neoplasia can also be studied. By using type-specific primers and two steps of PCR, the present work attempted to clarify the prevalence of cervical HPV types 6, 11 , 16 or 18 infection, either single or multiple, among patients with various grades of cervical neoplasia.
Materials and methods

Subjects and specimens
Four groups of patients were studied. Group A (n = 72) comprised patients with normal cervices (aged 16-65, mean 38.0 years). Group B (n = 55) were patients with low-grade SILs (aged 25-66, mean 41.2 years). Group C (n = 53) were patients with high-grade SILs (aged 25-62, mean 41.2 years). Group D (n = 47) were patients with cervical carcinomas (aged 32-69, mean 5 1.5 years). Patients with cervical carcinomas were significantly older than patients with normal cervices or cervical SILs (p < 0.001). Most cases came from the out-patient or colposcopy clinic, but some cases of cervical carcinoma were collected from ward patients before radical operation or radiotherapy. The diagnoses were based on the pathological reports of cervical biopsy samples. Patients with normal cervices had negative cervical pathology in addition to normal Papanicolaou smear results and colposcopic findings. The target DNA was extracted from cells of repeated cervical scraping by a phenol-chloroform-ethanol method, and the concentrations of DNA in the samples were determined by spectrophotometry [ 181.
Oligonucleotide primers
The primers for HPV 6, 11, 16 and 18 detection were synthesised by a DNA synthesiser (Model 381A, Applied Biosystems Inc., CA, USA) and purified by oligonucleotide purification cartridges (Applied Biosystems). All the primers were derived from the most conserved E6 or regulatory region of the HPV genome [19] . The sequences of the primers are shown in Table 1 .
PCR
The PCR was done as described previously [14] . Briefly, cellular genomic DNA (500 ng) and purified HPV DNA (100 pg, positive control) were amplified in a reaction mixture (1 00 pl) containing: PCR buffer, primer mix, deoxynucleoside triphosphate mix and Tuq DNA polymerase. Salmon sperm DNA (500 ng) was used as the negative control and reaction mixture without genomic DNA was used as the blank. Amplification was performed with an automated thermal cycler (Perkin-Elmer Cetus, USA) with denaturing conditions of 95°C for 2 min, followed by 35 cycles of 94"C, 55°C and 72°C for 1 min each, and a final extension at 72°C for 10 min. After the first-step PCR, a portion (10 pl) of the reaction mixture was used as the source of target DNA in the second-step PCR for further amplification. To avoid contamination, the PCR was prepared in a hood restricted to this purpose. There was overnight treatment of laminar flow and ultraviolet irradiation in the hood between each PCR run. The sensitivity of PCR was tested with serial dilutions of a known concentration of standard HPV DNA. As little as pg of standard HPV DNA could be detected at the end of the first-step PCR. The sensitivity increased to pg of standard HPV DNA after two step PCR.
After each step of the PCR, the reaction mixtures were tested for positive signals by gel electrophoresis ( Fig. 1 ) and dot-blot hybridisation (Fig. 2) [14] . Only those samples that gave the correct bands on electrophoresis and hybridisation signals were interpreted as positive for HPV infection. Patients with positive results by the first-step and by two steps of PCR were recorded and analysed separately.
Student's t test and cross-table x2 test were used for statistical analysis. A p value > 0.01 was considered to be non-significant. Fig. 2 . Dot-blot hybridisation of the PCR products with digoxigenin-labelled HPV DNA probes [14] . A, 1-5, positive controls for hybridisation, i.e., purified HPV DNA 1 ng, 100 pg, 10 pg, 1 pg, 0.1 pg, respectively; A, 6,7, the products of positive and negative PCR controls, respectively; the others are samples. The prevalence of single-type, negative and multiple HPV infections varied significantly among the four groups of patients (x2 = 38.8, p < 0.0001). Multiple HPV infections were most frequently seen in patients with low-grade SILs (6 1.8%). This prevalence decreased with increasing severity of cervical neoplasia (p < 0.0001). In contrast, single-type HPV infection was most commonly observed in patients with cervical carcinomas (6 1.7%), while the prevalence decreased with decreasing severity of cervical neoplasia (p < 0.001). It was noteworthy that HPV 16 was the predominant single-type infection in patients with cervical carcinoma and the prevalence of single-type HPV 16 infection decreased steadily with decreasing severity of cervical neoplasia (p < 0.0001). In contrast, HPV 11 was the predominant single-type infection in patients with normal cervices and the prevalence of single-type HPV 11 infection decreased with increasing severity of cervical neoplasia (p < 0.01). The prevalence of single-type, negative and multiple HPV infections based on individual case are suminarised in Table 2 .
The prevalence of HPV 6 infection, regardless of single of multiple status, in patients with normal cervices, low-grade SILs, high-grade SILs and cervical carcinomas was 6.9%, 14.5%, 15.1% and 10.6.%, respectively, while that of HPV 18 was 16.7%, 36.4%, 26.4% and 2 1.3%, respectively. The prevalence of HPV 16 infection in patients with various grades of cervical neoplasia ranged from 63% to 69.1%. These were much greater than that (23.6%) of patients with normal cervices (p < 0.0001). HPV 11 infection was most frequently (50.9%) seen in patients with lowgrade SILs, and the prevalence decreased with increasing severity of cervical neoplasia (p < 0.001).
Generally, those with increasing severity of cervical neoplasia were more likely to be positive by first round PCR, and especially for HPV 16 infection (p < 0.0001). The prevalences of each HPV infection regardless of single or multiple status are summarised in Table 3 .
Discussion
Women with cervical neoplasia generally have HPV infection more frequently than those with normal cervices. In the present work, the prevalence of HPV 6, 11, 16 or 18 infection in patients with various grades of cervical neoplasia (71.7-83.6%) was greater than that (58.3%) in patients with normal cervices (p < 0.01) ( Table 2 ). The prevalence (58.3%) of HPV DNA in samples of normal cervices examined by PCR is relatively higher in the present work but is still within the range 5-70% reported previously and is generally greater than those obtained by other conventional hybridisation methods [17,20,2 11. Theoretically, the odds ratio of HPV infection relating to cervical cancer becomes small when the prevalence of HPV infection in normal patients rises. In other words, the correlations of HPV infection with disease outcome weakens when disproportionately more normal controls are diagnosed to be HPV positive by a more sensitive detection method such as PCR [22] . 
~~~~ SIL, squamous intraepithelial lesion; PCR-I, positive at the end of the first-step PCR; PCR-2, positive by two steps of PCR.
Significant difference of the prevalence rates among various groups of patients, tp < 0.001, Ip < 0.0001.
$Proportion of positivity by the first-step PCR.
Lauricella-Lefebvre and colleagues screened cervical smears for HPV types 6, 11, 16 and 18 infections in 450 patients involved in a clinical follow-up of cervical HPV infection and found that HPV 16 was the most common single-type infection (25.4%) [23] .
In the present work, the prevalence of single-type HPV infection (6 1.7%) was much greater in patients with cervical carcinoma than that (21 3%-36.1%) in other patient groups (p < 0.001). The predominance of single-type HPV 16 infection in patients with cervical carcinoma may account for this discrepancy. The prevalence of single-type HPV 16 infection increased steadily from 8.3% in patients with normal cervices to 46.8% in those with cervical carcinoma (p < O.OOOl), which supports a role for HPV 16 in the pathogenesis of cervical cancer. On the other hand, the prevalence of HPV 11 infection decreased with increasing severity of cervical lesions (p < O.Ol), which suggests a benign nature of HPV 11 infection. The trend of change for those infected with HPV 6 or 18 was not so clear-cut in the present work.
A further finding of the present study was the detection of a large number of multiple HPV infections in patients with low-grade SILs. Simultaneous infection with more than one HPV type has not been reported frequently. Hinrichs and colleagues demonstrated two types of HPVs occupying distinct and non-overlapping foci within the lesions by in situ hybridisation [24] . The reported prevalence of multiple HPV infections has varied greatly in different studies [23, 25] . In the present study, the prevalence of multiple HPV infections seems to vary with the severity of cervical lesions, being 61. The prevalence of multiple HPV infections varies among different detection methods. Theoretically, more HPVs present at low copy number could be detected when a more sensitive method is applied; thus, the frequency of detection of multiple infections will be higher. In fact, multiple infections are more commonly observed with PCR methods than when DNA hybridisation techniques are used [2, 17,271. Moreover, the difference in sensitivity between the one-step and two steps of PCR is evident [14] . The copy numbers of HPV DNA in samples positive for amplification at the end of the first-step PCR are generally larger than those positive only following two steps of PCR. In the present study, the prevalence of HPV 16 infection detected by two steps of PCR began to rise abruptly in patients with low-grade SILs (69.1% versus 23.6% in those with normal cervices), while the prevalence of HPV 16 by the first-step PCR rose gradually along with the severity of cervical neoplasia (p < 0.0001) ( Table 3) . These findings might suggest that most cases of cervical dysplasia progressed with the acquisition of a low copy-number of the 'oncogenic' HPV 16 DNA [28] , while the accumulation of large copy-number of HPV 16 DNA develops later in more advanced lesions. However, whether this trend of change in virus status is the cause or the result of the malignant process remains to be clarified. It is also difficult to know what contribution is made by low-risk types 6/11 in association with high risk types 16/18 in cervical cancer and what is the contribution of any of the different types in dysplasia. Perhaps these HPVs might just happen to be associated with cervical neoplasia.
Nuovo and colleagues reported that infection by one type is rarely associated with concurrent active infection by a second HPV type [2] . It is possible that an existing HPV infection may inhibit or limit the replication of other types of HPV, or the presence of certain HPV DNA, especially of large copy number, may interfere and prevent other types of HPV DNA from being detected by PCR [24, 29] . PCR with typespecific instead of consensus primers may prevent this technical interference. The other important factor to account for the finding of a predominance of singletype HPV infection in cervical carcinomas may be related to a sampling bias. Because well-developed carcinomas usually originated and grew monoclonally, tests on samples derived from 'monoclonal' cancer cells may lead to a higher likelihood of obtaining a single HPV type. Moreover, in the present work, patients with cervical carcinomas were significantly older and had higher prevalence of HPV 16 infection than other groups of patients. Prevalence of HPV in cytomorphologically normal cervical smears is agedependent [30] . Generally, increasing age is significantly associated with a lower prevalence of HPV infection [31] . However, infection with HPV types 16 and 18 is not related to the age of patients with cervical cancer [32, 33] . Therefore, age appears to be a potentially confounding variable but should not be an exclusive and definitive factor [34] .
